Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 76
Filter
1.
Rev. chil. endocrinol. diabetes ; 10(3): 107-110, jul. 2017. ilus, tab
Article in Spanish | LILACS | ID: biblio-998995

ABSTRACT

Infundibuloneurohypophysitis is a rare condition, which is part of the group of hypophysitis, of relatively recent description (1993). The main clinical manifestation is diabetes insipidus, whose natural evolution is towards chronicity. The differential diagnosis with other thickening of the hypophysial stem is very important, where the clinic, imaging, laboratory and eventually biopsy are a main support for a correct diagnosis. We present a clinical case that shows the usual picture of infundibuloneurohypophysitis, and illustrates the imaging evolution in a female patient, with diabetes insipidus as the main clinical manifestation


Subject(s)
Humans , Female , Adult , Pituitary Diseases/complications , Pituitary Diseases/diagnosis , Diabetes Insipidus/etiology , Pituitary Diseases/diagnostic imaging , Polyuria/etiology , Polyuria/drug therapy , Deamino Arginine Vasopressin/therapeutic use , Diabetes Insipidus/drug therapy , Diuresis/drug effects , Antidiuretic Agents/therapeutic use , Polydipsia/etiology , Polydipsia/drug therapy
2.
J. pediatr. (Rio J.) ; 91(5): 428-434, Sept.-Oct. 2015. tab, graf
Article in English | LILACS | ID: lil-766170

ABSTRACT

ABSTRACT OBJECTIVE: To compare two electrolyte maintenance solutions in the postoperative period in children undergoing appendectomy, in relation to the occurrence of hyponatremia and water retention. METHODS: A randomized clinical study involving 50 pediatric patients undergoing appendectomy, who were randomized to receive 2,000 mL/m2/day of isotonic (Na 150 mEq/L or 0.9% NaCl) or hypotonic (Na 30 mEq/L NaCl or 0.18%) solution. Electrolytes, glucose, urea, and creatinine were measured at baseline, 24 h, and 48 h after surgery. Volume infused, diuresis, weight, and water balance were analyzed. RESULTS: Twenty-four patients had initial hyponatremia; in this group, 13 received hypotonic solution. Seventeen patients remained hyponatremic 48 h after surgery, of whom ten had received hypotonic solution. In both groups, sodium levels increased at 24 h (137.4 ± 2.2 and 137.0 ± 2.7 mmol/L), with no significant difference between them (p = 0.593). Sodium levels 48 h after surgery were 136.6 ± 2.7 and 136.2 ± 2.3 mmol/L in isotonic and hypotonic groups, respectively, with no significant difference. The infused volume and urine output did not differ between groups during the study. The water balance was higher in the period before surgery in patients who received hypotonic solution (p = 0.021). CONCLUSIONS: In the post-appendectomy period, the use of hypotonic solution (30 mEq/L, 0.18%) did not increase the risk of hyponatremia when compared to isotonic saline. The use of isotonic solution (150 mEq/L, 0.9%) did not favor hypernatremia in these patients. Children who received hypotonic solution showed higher cumulative fluid balance in the preoperative period.


RESUMO OBJETIVO: Comparar duas soluções de manutenção hidroeletrolítica no período pós-operatório (PO) de crianças submetidas à apendicectomia quanto à ocorrência de hiponatremia e retenção hídrica. MÉTODOS: Estudo clínico randomizado que envolveu 50 pacientes pediátricos submetidos à apendicectomia, randomizados para receber 2.000 ml/m2/dia de solução isotônica (Na 150 mEq/L ou NaCl 0,9%) ou hipotônica (Na 30mEq/L ou NaCl 0,18%). Eletrólitos, glicose, ureia e creatinina foram mensurados no início do estudo, 24 e 48 horas após a cirurgia. Foram analisados volume infundido, diurese, peso e balanço hídrico. RESULTADOS: Apresentaram hiponatremia inicial 24 pacientes. Desses, 13 receberam solução hipotônica. Dezessete pacientes permaneceram hiponatrêmicas 48 horas após a cirurgia, 10 haviam recebido solução hipotônica. Nos dois grupos os níveis de sódio aumentaram na 24ª hora PO (137,4 ± 2,2 e 137,0 ± 2,7) e não houve diferença entre eles (p = 0,593). Níveis de sódio 48 h após a cirurgia foram 136,6 ± 2,7 e 136,2 ± 2,3 no grupo isotônico e hipotônico respectivamente sem diferença significativa. Os volumes infundidos e a diurese não diferiram entre os grupos durante o estudo. O balanço hídrico foi maior no período anterior à cirurgia no grupo de pacientes que receberam solução hipotônica (p = 0,021). CONCLUSÕES: No período pós-apendicectomia, o uso da solução hipotônica não aumentou o risco de hiponatremia quando comparado com uma solução salina isotônica. O uso da solução isotônica não favoreceu a hipernatremia nesses pacientes. Crianças que receberam solução hipotônica apresentaram maior balanço hídrico cumulativo no período pré-operatório.


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Appendectomy , Fluid Therapy/methods , Hyponatremia/prevention & control , Postoperative Complications/prevention & control , Appendectomy/adverse effects , Double-Blind Method , Diuresis/drug effects , Glucose/administration & dosage , Hyponatremia/blood , Hypotonic Solutions/administration & dosage , Infusions, Intravenous , Isotonic Solutions/administration & dosage , Postoperative Period , Preoperative Period , Prospective Studies , Potassium Chloride/administration & dosage , Sodium Chloride/administration & dosage , Sodium/blood
3.
Rev. chil. cardiol ; 34(2): 120-129, 2015. graf, tab
Article in Spanish | LILACS | ID: lil-762613

ABSTRACT

Introducción: Angiotensina (Ang)-(1-9) posee propiedades anti-hipertensivas y efecto protector a nivel cardiovascular en ratas hipertensas. Sin embargo, se desconoce si estos efectos están asociados a un mecanismo de desbalance de sodio a nivel renal. Objetivo: Determinar si el efecto anti-hipertensivo de Ang-(1-9) está asociado a un mecanismo diurético-na-triurético. Método: Ratas macho Sprague Dawley (200 ± 10g) fueron aleatorizadas para recibir Ang II (400 ng/kgmin) vía bomba osmótica. Como control se utilizaron ratas con operación sham (n=18). Después de 2 semanas desde la instalación de bomba, las ratas Sham e hipertensas fueron randomizadas para recibir vehículo (n=10), Ang-(1-9) (602 ng/kg/min, n=17) o una co-administración de Ang-(1-9) y A779 (100 ng kg-1min-1, n=7 bloqueador del receptor MAS) por 2 semanas. Resultados: Se determinó la presión arterial sistólica (PAS), masa ventricular relativa (MVR), área y perímetro de los cardiomiocitos (AC y PC) y la fracción volumétrica de colágeno total (FVCT). Para evaluar la diuresis y natriuresis se utilizaron ratas normotensas que fueron randomizadas para recibir vehículo (n=8) o Ang-(1-9) (600 ngKg-1min-1, n=8) por 6 días. Se observó un incremento significativo(p<0.05) de PAS (33%), MVR (17%), AC (64%), PC (20%), FVCT (46%). La administración crónica de Ang-(1-9) disminuyó PAS (20%), MVR (13 %), AC (35%), PC (20%) y FVCT (20%). Estos efectos no fueron mediados por el receptor MAS. Al comparar las ratas normotensas tratadas con vehículo o Ang-(1-9), se observó un aumento significativo de la diuresis y natriuresis en los días 2 y 3 en los animales con infusión de Ang-(1-9). Conclusión: Ang-(1-9) reduce la hipertensión y el remodelamiento cardíaco en ratas hipertensas. En animales normotensos se demostró que el tratamiento con Ang-(1-9)-induce diuresis y natriuresis. Este es el primer reporte que señala que el efecto de Ang-(1-9) está asociado a una regulación del sodio a nivel renal.


Background: Angiotensin-(1-9) has anti-hypertensive properties and protective cardiovascular effect in hypertensive rats. However, it is unknown whether its effects are related to a kidney mechanism to balance sodium. Aim: To determine if the anti-hypertensive effect of Ang-(1-9) is associated to a diuretic-natriuretic mechanism. Method: Sprague Dawley male rats (200±10 grs) were randomized to receive Angiotensin II by osmotic pump (400 ng/kg/min). Sham operated rats were utilized as control (n=18). Two weeks after pump setting, Sham rats with hypertension were randomized to receive placebo (n=10), Ang-(1-9)(602 ng/kg/min, n=17) or Ang-(1-9) plus A779 (Ang-(1-7) Receptor Mas blocker, 100ng/kg-1min-1, n=7) co-administration for two weeks. Arterial systolic pressure (PAS), ventricular relative mass (MVR), cardiomyocytes area and perimeter (AC and PC) and total collagen volume fraction (FVCT) were measured. Normotensive rats were utilized to evaluate diuresis and natriuresis which were randomized to receive placebo (n=8) or Ang-(1-9) (600ng/kg-1/min-1, n=8) for six days. Results: It was observed a significant rise (p<0.05) of PAS (33%), MVR (17%), AC (64%), PC (26%), FVCT (46%) was observed. Chronic administration of Ang-(1-9) reduced PAS (20%), MVR (13%), AC (35%), PC (20%) and FCVT (20%). All those effects were not mediated by Mas receptor. A significant raise was observed of diuresis and natriuresis at the second and third day of treatment in rats receiving Ang-(1-9) in comparison with normotensive rats treated with placebo. Conclusion: Ang-(1-9) reduces hypertension and cardiac remodeling in hypertensive rats. Ang-(1-9) induces natriuresis and diuresis in normotensive rats. This is the first report showing that Ang-(1-9) is associated to sodium balance in the kidney.


Subject(s)
Animals , Rats , Angiotensin II/pharmacology , Diuresis/drug effects , Natriuresis/drug effects , Antihypertensive Agents/pharmacology , Rats, Sprague-Dawley , Heart/drug effects
4.
Rev. Assoc. Med. Bras. (1992) ; 60(3): 208-215, May-Jun/2014. tab, graf
Article in English | LILACS | ID: lil-713065

ABSTRACT

Objective: to evaluate the effects of early norepinephrine (NE) infusion in children submitted to mechanical ventilation (MV) requiring continuous sedative and analgesic infusion. Methods: double-blinded, randomized, placebo-controlled trial enrolling children (1 month to 12 years of age) admitted to a Brazilian PICU and expected to require MV and continuous sedative and analgesic drug infusions for at least five days. Children were randomized to receive either norepinephrine (NE) (0.15 mcg/kg/min) or normal saline infusion, started in the first 24 hours of MV, and maintained for 72 hours. We compared hemodynamic variables, fluid intake, renal function and urine output between groups. Results: forty children were equally allocated to the NE or placebo groups, with no differences in baseline characteristics, laboratorial findings, PRISM II score, length of MV, or mortality between groups. The average norepinephrine infusion was 0.143 mcg/kg/min. The NE group showed higher urine output (p = 0.016) and continuous increment in the mean arterial pressure compared to the baseline (p = 0.043). There were no differences in the remaining hemodynamic variables, fluid requirements, or furosemide administration. Conclusion: early norepinephrine infusion in children submitted to MV improves mean arterial pressure and increases urine output. These effects were attributed to reversion of vasoplegia induced by the sedative and analgesic drugs. .


Objetivo: avaliar os efeitos da infusão de noradrenalina (NA) em crianças submetidas a ventilação mecânica (VM) requerendo infusão contínua de sedoanalgesia. Métodos: estudo duplo cego, randomizado e placebo controlado envolvendo crianças de 1 mês a 12 anos, admitidas em uma UTI pediátrica brasileira com a expectativa de necessidade de VM e sedoanalgesia por, no mínimo, 5 dias. As crianças foram randomizadas a receber infusão de NA (0,15 mcg/kg/min) ou solução salina, iniciadas nas primeiras 24 horas de VM e mantidas por 72 horas. Comparamos as variáveis hemodinâmicas, oferta hídrica, função renal e débito urinário entre os dois grupos. Resultados: 40 crianças foram alocadas aos grupos NA e placebo, sem diferenças nas características basais, achados laboratoriais, escore PRISM II, tempo de VM ou mortalidade. A infusão média de NA foi 0,143 mcg/kg/min. O grupo NA apresentou maior débito urinário (p = 0,016) e aumento constante da pressão arterial média quando comparado aos níveis basais (p = 0,043). Não se observou diferenças nas demais variáveis hemodinâmicas, reposição hídrica ou no uso de furosemida. Conclusão: infusão precoce de NA em crianças submetidas a VM em uso sedoanalgesia promove aumento na pressão arterial média e aumento da diurese. Esses efeitos são atribuídos à reversão da vasoplegia induzida pelas drogas sedativas e analgésicas. .


Subject(s)
Child , Child, Preschool , Female , Humans , Infant , Male , Blood Pressure/drug effects , Diuresis/drug effects , Norepinephrine/administration & dosage , Vasoconstrictor Agents/administration & dosage , Analgesics/adverse effects , Brazil , Dose-Response Relationship, Drug , Double-Blind Method , Heart Rate/drug effects , Hypnotics and Sedatives/adverse effects , Infusion Pumps , Intensive Care Units, Pediatric , Norepinephrine/pharmacology , Pilot Projects , Respiration, Artificial , Vasoconstrictor Agents/pharmacology
5.
Biomédica (Bogotá) ; 33(1): 115-121, ene.-mar. 2013. ilus, graf
Article in Spanish | LILACS | ID: lil-675139

ABSTRACT

Introducción. Ceratopteris pteridoides es un helecho semiacuático de la familia Parkeriacea, ampliamente utilizado en la medicina popular colombiana como diurético y colelitiásico, sobre el cual no existen reportes científicos que avalen su uso popular como diurético. Objetivo. Evaluar el efecto diurético agudo en dosis única y dosis repetidas a corto plazo, de los extractos etanólico y acuoso de C. pteridoides en un modelo in vivo . Materiales y métodos. El extracto etanólico total fue obtenido por maceración de la planta entera de C. pteridoides con etanol y el extracto acuoso fue obtenido por decocción a 60 °C por 15 minutos. Ambos extractos se sometieron a análisis fitoquímico preliminar y estudio histológico posterior a la administración de los extractos durante ocho días consecutivos (1.000 mg/kg). El efecto diurético se evaluó en ratas Wistar, tratadas con los extractos (500 mg/kg), en forma aguda y en dosis repetidas a corto plazo, cuantificando la eliminación de agua y la excreción renal de sodio y potasio por espectrofotometría de absorción atómica y, de cloruros, por titulación mercurimétrica. Resultados. En el modelo agudo, ambos extractos mostraron un significativo efecto diurético y de excreción renal de sodio y potasio en comparación con el control, mientras que con la administración en dosis repetidas a corto plazo mostraron efecto diurético sin eliminación de electrolitos. El estudio histopatológico no sugirió efectos tóxicos hepáticos o renales. Conclusión. Los resultados demuestran la actividad diurética de C. pteridoides y sustentan el uso popular dado a esta planta como diurético en la costa norte colombiana. Se requieren estudios posteriores que permitan aislar e identificar los compuestos responsables de la actividad y los mecanismos de acción involucrados.


Introduction. Ceratopteris pteridoides is a semiaquatic fern of the Parkeriacea family, widely used in the Colombian folk medicine as a diuretic and cholelithiasic, of which there are no scientific reports that validate its popular use. Objective. To evaluate the acute and short-term repeated-dose diuretic effect of the ethanolic and aqueous extracts of C. pteridoides in an in vivo model. Materials and methods. The total ethanolic extract was obtained by maceration of the whole plant of C. pteridoides with ethanol and the aqueous extract by decoction at 60°C for 15 minutes. Both extracts were evaluated in preliminary phytochemical analysis and histological studies after the administration of the extracts for 8 consecutive days (1000 mg/Kg). The diuretic effect was evaluated using Wistar rats treated with the extracts (500 mg/Kg), using an acute and a short-term repeated-dose model, and quantifying water elimination, sodium and potassium excretion by atomic absorption spectrophotometry, and chloride excretion by mercurimetric titration. Results. In the acute model both extracts showed significant diuretic, natriuretic, and kaliuretic effect compared to the control group. Whereas, a short-term repeated-dose administration showed a diuretic effect without elimination of electrolytes. The histopathologic study did not suggest a toxic effect in liver or kidney. Conclusion. The results represent evidence of the diuretic activity of C. pteridoides and give support the popular use given to this plant in the north coast of Colombia. Further studies are required to isolate and identify the compounds responsible for the activity and the mechanism of action involved.


Subject(s)
Animals , Female , Rats , Diuresis/drug effects , Diuretics/pharmacology , Plant Extracts/pharmacology , Pteridaceae/chemistry , Colombia , Chlorides/urine , Drug Evaluation, Preclinical , Diuretics/administration & dosage , Diuretics/isolation & purification , Diuretics/toxicity , Ethanol , Furosemide/pharmacology , Kidney/drug effects , Kidney/ultrastructure , Liver/drug effects , Liver/ultrastructure , Medicine, Traditional , Natriuresis/drug effects , Phytotherapy , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification , Plant Extracts/toxicity , Potassium/urine , Rats, Wistar , Solvents , Water
6.
Article in English | IMSEAR | ID: sea-135536

ABSTRACT

Background & objectives: Athletes in Malaysia need to perform in a hot and humid climate. Chronic supplementation of caffeine on endurance performance have been studied extensively in different populations. However, concurrent research on the effects of acute supplementation of caffeine on cardiorespiratory responses during endurance exercise in the Malaysian context especially in a hot and humid environment is unavailable. Methods: Nine heat adapted recreational Malaysian male runners (aged: 25.4 + 6.9 yr) who were nonusers of caffeine (23.7 + 12.6 mg per day) were recruited in this placebo - controlled double - blind randomized study. Caffeine (5 mg per kg of body weight) or placebo was ingested in the form of a capsule one hour prior to the running exercise trial at 70 per cent of VO2max on a motorised treadmill in a heat-controlled laboratory (31oC, 70% relative humidity). Subjects drank 3 ml of cool water per kg of body weight every 20 min during the running trials to avoid the adverse effects of dehydration. Heart rate, core body temperature and rate of perceived exertion (RPE) were recorded at intervals of 10 min, while oxygen consumption was measured at intervals of 20 min. Results: Running time to exhaustion was significantly (P<0.05) higher in the caffeine trial compared to the placebo trial. Heart rate, core body temperature, oxygen uptake and RPE did not show any significant variation between the trials but it increased significantly during exercise from their respective resting values in both trials (P< 0.001). Interpretation & conclusion: Our study showed that ingestion of 5 mg of caffeine per kg of body weight improved the endurance running performance but did not impose any significant effect on other individual cardiorespiratory parameters of heat-acclimated recreational runners in hot and humid conditions.


Subject(s)
Adult , Body Composition , Body Mass Index , Body Temperature , Caffeine/pharmacology , Diuresis/drug effects , Double-Blind Method , Exercise/physiology , Heart Rate/drug effects , Humans , Malaysia , Male , Muscle, Skeletal/drug effects , Oxygen Consumption/drug effects , Oxygen Consumption/physiology , Performance-Enhancing Substances/pharmacology
8.
Braz. j. med. biol. res ; 42(1): 114-121, Jan. 2009. ilus
Article in English | LILACS | ID: lil-505427

ABSTRACT

We investigated the involvement of GABAergic mechanisms of the central amygdaloid nucleus (CeA) in unanesthetized rats subjected to acute isotonic or hypertonic blood volume expansion (BVE). Male Wistar rats bearing cannulas unilaterally implanted in the CeA were treated with vehicle, muscimol (0.2 nmol/0.2 µL) or bicuculline (1.6 nmol/0.2 µL) in the CeA, followed by isotonic or hypertonic BVE (0.15 or 0.3 M NaCl, 2 mL/100 g body weight over 1 min). The vehicle-treated group showed an increase in sodium excretion, urinary volume, plasma oxytocin (OT), and atrial natriuretic peptide (ANP) levels compared to control rats. Muscimol reduced the effects of BVE on sodium excretion (isotonic: 2.4 ± 0.3 vs vehicle: 4.8 ± 0.2 and hypertonic: 4.0 ± 0.7 vs vehicle: 8.7 ± 0.6 µEq·100 g-1·40 min-1); urinary volume after hypertonic BVE (83.8 ± 10 vs vehicle: 255.6 ± 16.5 µL·100 g-1·40 min-1); plasma OT levels (isotonic: 15.3 ± 0.6 vs vehicle: 19.3 ± 1 and hypertonic: 26.5 ± 2.6 vs vehicle: 48 ± 3 pg/mL), and ANP levels (isotonic: 97 ± 12.8 vs vehicle: 258.3 ± 28.1 and hypertonic: 160 ± 14.6 vs vehicle: 318 ± 16.3 pg/mL). Bicuculline reduced the effects of isotonic or hypertonic BVE on urinary volume and ANP levels compared to vehicle-treated rats. However, bicuculline enhanced the effects of hypertonic BVE on plasma OT levels. These data suggest that CeA GABAergic mechanisms are involved in the control of ANP and OT secretion, as well as in sodium and water excretion in response to isotonic or hypertonic blood volume expansion.


Subject(s)
Animals , Male , Rats , Amygdala/drug effects , Bicuculline/pharmacology , Blood Volume/drug effects , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , Muscimol/pharmacology , Amygdala/physiology , Atrial Natriuretic Factor/blood , Bicuculline/administration & dosage , Blood Volume/physiology , Diuresis/drug effects , Diuresis/physiology , GABA Agonists/administration & dosage , GABA Antagonists/administration & dosage , Muscimol/administration & dosage , Oxytocin/blood , Rats, Wistar , Sodium/urine
9.
Acta bioquím. clín. latinoam ; 41(1): 67-76, ene.-mar. 2007. graf, tab
Article in Spanish | LILACS | ID: lil-632996

ABSTRACT

Estudios previos en ratas han demostrado que la administración del diurético furosemida aumenta la pérdida urinaria de electrolitos y nutrientes, causando un efecto negativo sobre las reservas de los mismos. Una alternativa para proteger esas reservas es incrementar la absorción intestinal. Así, se evaluó la absorción, pérdidas urinarias y reservas corporales de nitrógeno, calcio, magnesio, sodio, potasio y cinc, en cuatro grupos de ratas: control, y tres grupos experimentales que consumieron furosemida en concentraciones de 0,5; 1,0 y 1,5 mg/g de dieta, durante 23 días. El diurético causó poliuria dosis dependiente, disminución en el consumo de alimento, la eficiencia y el crecimiento. También, provocó un aumento en las pérdidas urinarias del nitrógeno y minerales. La absorción de nitrógeno, calcio y cinc no se modificó, mientras que la del magnesio, sodio y potasio aumentó ligeramente. Se determinó que la absorción no compensó las pérdidas urinarias. Así, la furosemida afectó negativamente la retención de nutrientes y electrolitos, provocando una reducción en las reservas corporales de los mismos. Este diurético tiene un efecto negativo sobre el estado nutricional en ratas, causado por la reducción en el consumo de alimento, así como en la utilización de los nutrientes consumidos. La reducción en la utilización de los nutrientes asociada con este diurético, puede ser explicada en parte, por una pobre retención de nutrientes por el riñón, que no puede ser compensada por un incremento en la absorción intestinal.


Previous studies have shown that, in rats, the administration of the diuretic furosemide increases diuresis as well as urinary loss of electrolytes and essential nutrients. This loss has a negative effect on electrolytes and nutrient reserves. Since one alternative to help protect these reserves is to increase intestinal absorption, the purpose of this study was to evaluate the absorption, urinary loss and tissue reserves of nitrogen, calcium, magnesium, sodium, potassium and zinc in rats offered 0, 0.5, 1.0 and 1.5 mg furosemide per g diet, daily during 23 days. The diuretic caused a dose dependent polyuria, a reduction in food intake, growth and feed efficiency. In addition, those rats had increased urinary loss of nitrogen and minerals. Nitrogen, calcium and zinc absorption were not affected, but magnesium, sodium and potassium increased slightly. Intestinal absorption could not compensate for urinary loss. In general, this study showed that in rats, this diuretic had a negative effect on nutritional status caused by a reduction in food intake and also in the utilization of the nutrients consumed. The reduction in nutrient utilization associated with this diuretic may be partly explained by a poor nutrient retention by the kidney which was not compensated by an increase in intestinal absorption.


Subject(s)
Animals , Rats , Diuresis/drug effects , Furosemide/pharmacokinetics , Ascorbic Acid/urine , Thiamine/urine , Bicarbonates/pharmacokinetics , Food , Calcium/urine , Calcium/pharmacokinetics , Rats, Sprague-Dawley , Vitamin B 6/urine , Diet Therapy/veterinary , Furosemide/administration & dosage , Furosemide/antagonists & inhibitors , Furosemide/adverse effects , Furosemide/metabolism , Furosemide/urine
10.
Indian J Exp Biol ; 2000 Jun; 38(6): 607-9
Article in English | IMSEAR | ID: sea-56698

ABSTRACT

Hypoglycemic, diuretic and hypocholesterolemic effects of roots of W. somnifera (ashvagandha) were assessed on human subjects. Six mild NIDDM subjects and six mild hypercholesterolemic subjects were treated with the powder of roots of W. somnifera for 30 days. Suitable parameters were studied in the blood and urine samples of the subjects along with dietary pattern before and at the end of treatment period. Decrease in blood glucose was comparable to that of an oral hypoglycemic drug. Significant increase in urine sodium, urine volume, significant decrease in serum cholesterol, triglycerides, LDL (low density lipoproteins) and VLDL (very low density lipoproteins) cholesterol were observed indicating that root of W. somnifera is a potential source of hypoglycemic, diuretic and hypocholesterolemic agents. Clinical observations revealed no adverse effects.


Subject(s)
Adult , Anticholesteremic Agents/adverse effects , Blood Glucose/analysis , Capsules , Diabetes Mellitus, Type 2/drug therapy , Diuresis/drug effects , Diuretics/adverse effects , Humans , Hypercholesterolemia/drug therapy , Hypoglycemic Agents/adverse effects , Lipids/blood , Middle Aged , Natriuresis/drug effects , Plant Extracts/adverse effects , Plant Roots/chemistry , Plants, Medicinal/chemistry , Potassium/analysis , Powders , Sodium/analysis , Solanaceae/chemistry
11.
Rev. Fac. Med. UNAM ; 42(6): 218-21, nov.-dic. 1999. tab
Article in Spanish | LILACS | ID: lil-276423

ABSTRACT

Es indispensable conservar la función renal de los pacientes con cirrosis hepática, ya que la insuficiencia renal se asocia con una alta morbimortalidad en dichos países. La vasoconstricción sistémica, la disminución del flujo sanguíneo renal y la disminución de metabolitos urinarios de prostaglandinas son importantes en la patogénesis de esta nefropatía. El misoprostol, prostaglandina sintética, puede modificar favorablemente algunos de los cambios en la hemodinamia renal de la cirrosis. Objetivo: Evaluar los cambios de la función renal en el paciente cirrótico con el uso de misoprostol. Metodología: se estudiaron 15 pacientes con cirrosis hepática que había desarrollado ascitis, con creatinina sérica menor a 1.5 mg/dL. Se determinaron: depuración de creatinina, volumen urinario, excreción de sodio urinario y la fracción excretada del mismo en 24 h., el filtrado glomerular y el flujo sanguíneo renal bilateral antes y después de la administración vía oral e misoprostol. Se aceptó un valor significativo a p < 0.05. resultados: Se encontró mejoría significativa únicamante en el flujo sanguíneo renal (p= 0.02), después de la administración de misoprostol. Sin embargo, al separar a los pacientes en dos grupos: los que usan diuréticos y aquellos que no los usan, se obtiene una diferencia significativa en el filtrado glomerular (p < 0.001), el flujo sanguíneo renal (p < 0.01) y la diurésis (p < 0.001). No hubo diferencias significativas en otros parámetros. Conclusiones: El uso de misoprostol en los pacientes cirróticos que utilizan diuréticos para el tratamiento de asitis y retención hídrica, mejora los parámetros de la función renal, al incrementar el flujo sanguíneo renal, el filtrado glomerular y la diuresis, actuando como vasodilatador en las arterias renales


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Liver Cirrhosis/complications , Liver Cirrhosis/urine , Liver Cirrhosis/therapy , Misoprostol/therapeutic use , Prostaglandins E/therapeutic use , Acute Kidney Injury/etiology , Acute Kidney Injury/therapy , Diuresis/drug effects
12.
Rev. cuba. plantas med ; 4(1): 22-5, ene.-abr. 1999. tab, graf
Article in Spanish | LILACS | ID: lil-295469

ABSTRACT

Se realizó un estudio experimental en ratas línea Wistar, con el objetivo de evaluar el posible efecto diurético del extracto fluido, en solución hidroalcohólica al 65 porciento de Xanthium strumarium L. Para el mismo se probaron 3 niveles de dosis: 100,200 y 400 mg/Kg de peso corporal. Los resultados fueron comparados con los obtenidos por la Furosemida en la dosis de 5 mg/Kg de peso (diurético de referencia) y con el cloruro de sodio 0,9 porciento (control). La excreción urinaria se midió por hora hasta la sexta hora y se le determinó al volumen final la concentración de sodio y potasio. Se pudo comprobar la similitud entre la acción diurética del extracto y la Furosemida acompañada de natriuresis y kaluresis significativa


Subject(s)
Diuresis/drug effects , Diuretics , Drugs, Chinese Herbal , Plant Extracts/pharmacology , Rats, Wistar
13.
Braz. j. med. biol. res ; 31(9): 1221-7, sept. 1998. tab, graf
Article in English | LILACS | ID: lil-222969

ABSTRACT

In the present study we evaluated the nature of angiotensin receptors involved in the antidiuretic effect of angiotensin-(1-7) (Ang-(1-7)) in water-loaded rats. Water diuresis was induced in male Wistar rats weighing 280 to 320 g by water load (5 ml/100 g body weight by gavage). Immediately after water load the rats were treated subcutaneously with (doses are per 100 g body weight): 1) vehicle (0.05 ml 0.9 percenr NaCl); 2) graded doses of 20, 40 or 80 pmol Ang-(1-7); 3) 200 nmol Losartan; 4) 200 nmol Losartan combined with 40 pmol Ang-(1-7); 5) 1.1 or 4.4 nmol A-779; 6) 1.1 nmol A-779 combined with graded doses of 20, 40 or 80 pmol Ang-(1-7); 7) 4.4 nmol A-779 combined with graded doses of 20, 40 or 80 pmol Ang-(1-7); 8) 95 nmol CGP 42112A, or 9) 95 nmol CGP 42112A combined with 40 pmol Ang-(1-7). The antidiuretic effect of Ang-(1-7) was associated with an increase in urinary Na+ concentration, an increase in urinary osmolality and a reduction in creatinine clearance (CCr: 0.65 ñ 0.04 ml/min vs 1.45 ñ 0.18 ml/min in vehicle-treated rats, P<0.05). A-779 and Losartan completely blocked the effect of Ang-(1-7) on water diuresis (2.93 ñ 0.34 ml/60 min and 3.39 ñ 0.58 ml/60 min, respectively). CGP 42112A, at the dose used, did not modify the antidiuretic effect of Ang-(1-7). The blockade produced by Losartan was associated with an increase in CCr and with an increase in sodium and water excretion as compared with Ang-(1-7)-treated rats. When Ang-(1-7) was combined with A-779 there was an increase in CCr and natriuresis and a reduction in urine osmolality compared with rats treated with Ang-(1-7) alone. The observation that both A-779, which does not bind to AT1 receptors, and Losartan blocked the effect of Ang-(1-7) suggests that the kidney effects of Ang-(1-7) are mediated by a non-AT1 angiotensin receptor that is recognized by Losartan.


Subject(s)
Animals , Male , Rats , Angiotensin II/antagonists & inhibitors , Diuresis/drug effects , Drinking , Losartan/pharmacology , Peptide Fragments/pharmacology , Receptors, Angiotensin/physiology , Renal Agents/antagonists & inhibitors , Analysis of Variance , Angiotensin II/pharmacology , Kidney/drug effects , Rats, Wistar , Renal Agents/pharmacology
14.
Rev. biol. trop ; 44(1): 93-6, abr. 1996. tab, graf
Article in Spanish | LILACS | ID: lil-218414

ABSTRACT

The possible diuretic effect of the leaf extract of Cecropia obtusifolia, Bertol; used in Costa Rican traditional medicine, was tested on five Sprague Dawley rats in individual metabolic cages. During the control week, distilled water was administered with an intragastric cannula. During the C. obtusifolia week, the rats were given the aqueous leaf extract in a daily dosage of 500 mg/kg, intragastricly. Although, the urinary flow was increased (p < 0.05) by a 20 per cent, there was no statistically significant difference between the following parameters: excretion in urine of osmoles, sodium and potassium; daily ingestion of food and water. The animal weights decreased when C. obtusifolia was used, but only on the fourth day the decrease was significant (p < 0.05). In conclusion, the aqueous leaf extract of C. obtusifolia has a slight diuretic effect.


Subject(s)
Animals , Female , Rats , Diuresis/drug effects , Plant Extracts/pharmacology , Body Weight/drug effects , Hydrogen-Ion Concentration , Osmolar Concentration , Plant Extracts , Potassium/metabolism , Rats, Sprague-Dawley , Sodium/metabolism
15.
Braz. j. med. biol. res ; 29(4): 511-3, Apr. 1996. graf
Article in English | LILACS | ID: lil-163895

ABSTRACT

We determined the effect of intracerebroventricular (icv) administration of losartan, an angiotensin II NG II), subtype I receptor (AT1) antagonist, on icv carbachol-induced natriuresis, kaliuresis and antidiuresis in water-loaded male Holtzman rats (250-300 g) with a cannula implanted into the lateral ventricle (LV). The rats were water loaded with 5 per cent of their body weight by gavage twice, with the second gavage one hour after the first. Carbachol (2 nmol in mul) was injected icv immediately after the second load. When losartan (DUP753, 50 nmol in 1 mul) was administered icv, it was given 3 min before carbachol. Previous icv treatment with losartan significantly reduced the icv carbachol-induced natriuresis (324 ñ 17 muEq/120 min), kaliuresis (103ñ15muEq /120min) and antidiuresis(13.5ñ2.1 ml/120 min) compared to the effects of previous icv injection of saline (Na+ excretion = 498 ñ 22 muEq/120 min; K+ excretion = 167 ñ 20 muEq/120 min; urine volume = 5.2 ñ 1.2 ml/l20 min). These results, reported as means ñ SEM for 12 rats in each group, are consistent with the hypothesis that AT1 subtype receptors participate in the regulation of body electrolyte balance.


Subject(s)
Male , Animals , Rats , Biphenyl Compounds/pharmacology , Carbachol/administration & dosage , Diuresis/drug effects , Imidazoles/pharmacology , Natriuresis/drug effects , Tetrazoles/pharmacology , Rats, Sprague-Dawley
16.
Indian J Physiol Pharmacol ; 1996 Jan; 40(1): 87-90
Article in English | IMSEAR | ID: sea-107734

ABSTRACT

In water loaded (5 ml/100 g) unanesthetized rats. nitrendipine (NT), nimodipine (NM) and nisoldipine (NS) (5 mg/ kg, i.p.) caused significant (P < 0.01) increase in water and Na+ excretion. However, there was no significant increase in K+ excretion after NT, NM and NS administration. NS was more potent in increasing excretion of water load as compared to NT and NM. The glomerular filtration rate as assessed by creatinine clearance, was significantly (P < 0.01) increased in NT, NM and NS (5 mg/kg, i.p.) treated groups as compared to control. The mean creatinine clearance values after NT, NM and NS were 26.95 +/- 0.35, 22.11 +/- 0.72 and 28.13 +/- 0.95 respectively as compared to 22.19 +/- 0.51, 18.77 +/- 0.42 and 22.97 +/- 0.60 in corresponding control groups. The results of the study suggest that in addition to other effects, NT, NM and NS have a selective inhibitory effect on Na+ handling mechanisms in the nephron.


Subject(s)
Animals , Calcium Channel Blockers/pharmacology , Creatinine/blood , Diuresis/drug effects , Electrolytes/urine , Female , Glomerular Filtration Rate , Male , Nimodipine/pharmacology , Nisoldipine/pharmacology , Nitrendipine/pharmacology , Rats
17.
Braz. j. med. biol. res ; 28(10): 1097-101, Oct. 1995. graf
Article in English | LILACS | ID: lil-161001

ABSTRACT

We determined the effects of two classical angiotensin II (ANG II) antagonists, [Sar1, Ala8]-ANG II and [Sar1, Thr8]-ANG II, and losartan (a nonpeptide and selective antagonist for the AT1 angiotensin receptors) on diuresis, natriuresis, kaliuresis and arterial blood pressure induced by ANG II administration into the median preoptic nucleus (MnPO) of male Holtzman rats weighing 250-300 g. Urine was colected in rats submitted to a water load (5 percent body weight) by gastric gavage, followed by a second water load (5 percent body weight) 1 h later. The volume of the drug solutions injected was 0.5 µl over 10-15 s. Pre-treatment with [Sar1, Ala8]-ANG II (12 rats) and [Sar1, Thr8]-ANG II (9 rats), at the dose of 60 ng reduced (13.7 +/- 1.0 vs 11.0 +/- 1.0 +/- 1.2, respectively), whereas losartam (14 rats) at the dose of 160 ng totally blocked (13.7 +/- 1.0 vs.7.6 +/- 1.5) the urine excretion induced by injection of 12 ng of ANG II (14 rats)...


Subject(s)
Animals , Male , Rats , Angiotensin II/pharmacology , Diuresis/drug effects , Natriuresis/drug effects , Arterial Pressure , Saralasin/pharmacology , Angiotensin II/administration & dosage , Angiotensin II/antagonists & inhibitors , Preoptic Area , Rats, Sprague-Dawley
18.
Braz. j. med. biol. res ; 27(8): 2043-7, Aug. 1994. tab
Article in English | LILACS | ID: lil-143623

ABSTRACT

1. Diabetes mellitus type 1 was induced in 3-month old maleC57 BL/KS-mdb mice (N = 24)) by ip injection of streptozotocin (STZ, 45 mg/Kg body weight) for 5 days. 2. To determine the possible protective effects of nitric oxide inhibition against hyperglycemia, the STZ-diabetic rats received two doses of Ng-nitro-l-arginine-methyl ester (L-NAME) (10 mg/Kg body weight and 10 mg/mouse) dissolved in PBS for 45 consecutive days. Another group of STZ-treated rats was similarly treated with L-arginine (5 mg/mouse). 3. Blood glucose levels were 118 ñ 37 mg/dl after 8 days of L-NAME administration (10 mg/Kg body weight, N = 12) and 186 ñ 22 mg/dl (N = 12) after 5 days of L-NAME administration at the 5 mg/mouse dose. Treatment with L-arginine (5-mg/mouse, N = 12) caused a significant increase in blood glucose level to 151 ñ 17,5 mg/dl, showing the relevance of nitric oxide formation in this type of diabetes. 4. In STZ-diabetic mice treated with L-NAME (N = 12), diuresis was reduced by approximately 58 per cents compared to STZ animals, whereas in L-arginine-treated animals (N = 12) diuresis returned to STZ levels. Urinary protein excretion, which, was significantly affected by STZ (123 per cents compared to control) was significanty reduced by 66 per cents after treatment with L-NAME for 45 days, whereas treatment with-L-arginine caused a return to STZ values. 5. Urinary kallikrein excretion, which was reduced by 80 per cents in STZ mice compared to control, returned to control levels after L-NAME treatment. 6. The present results suggest a relationship between nitric oxide levels and the reduction of diabetic state improved renal function by L-name


Subject(s)
Mice , Animals , Male , Diabetes Mellitus, Experimental/metabolism , Hyperglycemia/metabolism , Nitric Oxide/antagonists & inhibitors , Arginine/administration & dosage , Arginine/analogs & derivatives , Arginine/pharmacology , Blood Glucose/metabolism , Kallikreins/urine , Diabetes Mellitus, Type 1/chemically induced , Diabetes Mellitus, Type 1/metabolism , Diuresis/drug effects , Hyperglycemia/chemically induced , Nitric Oxide/metabolism , Proteinuria/metabolism , Time Factors
19.
Rev. méd. Chile ; 122(7): 737-45, jul. 1994. ilus
Article in Spanish | LILACS | ID: lil-136916

ABSTRACT

In order to clarify the blunting effect of peptides released by pepsin from blood plasma on ANP diuretic action, 2 prokinins designated PU-16 were tested. Both of them were able to inhibit in nanomolar doses the diuretic-saluretic action of 0.5 ug i.v. bolus of ANP given to anesthetized rats either by intravenous route or introduced in the duodenal lumen. PU-16 in doses of 0.5 ug and 1 ug were able to reduce in 72 and 96.5 per cent respectively the natriuresis induced bu 0.5 ug intravenous bolus of ANP. The data support the hypothesis that prokinins liberated in the digestive tract, could be physiological factors involved in hydrosaline homeostasis, moderating the ANP mediated increase of water, Na and K excretion during digestion


Subject(s)
Animals , Rats , Digestion/physiology , Digestive System , Diuresis/drug effects , Natriuresis/physiology , Atrial Natriuretic Factor/antagonists & inhibitors , Peptides/urine , Atrial Natriuretic Factor/pharmacokinetics
20.
Arq. bras. med. vet. zootec ; 46(1): 7-12, fev. 1994. ilus, tab
Article in English | LILACS | ID: lil-240054

ABSTRACT

Para estudar a diurese induzida por clonidina, esta substância foi administrada, por via intraperitoneal, em ratos. Intenso efeito diurético foi observado com doses entre 0,025 e 1,25 mg/kg, além de excreçäo aumentada de íons sódio e potássio. Esse efeito diurético foi intensamente inibido pela administraçäo prévia de ioimbina (bloqueador de receptores alfa-dois adrenérgicos) ou N-metil-nalorfina (bloqueador de receptores) opióides que penetra mal o sistema nervoso central). Por outro lado, seu efeito diurético foi aumentado, pela administraçäo prévia de naloxona, um bloqueador de receptores opióides mi. É provável que a ativaçäo de receptores alfa-dois adrenérgicos pela clonidina possa induzir a liberaçäo de substâncias endógenas opióides que causem diurese através da ativaçäo de receptores periféricos com baixa afinidade por naloxona


Subject(s)
Clonidine/pharmacokinetics , Diuresis/drug effects , Opioid Peptides/metabolism , Rats
SELECTION OF CITATIONS
SEARCH DETAIL